Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Oxid Med Cell Longev ; 2014: 703848, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25180069

RESUMO

Terpinen-4-ol (4TRP) is a monoterpenoid alcoholic component of essential oils obtained from several aromatic plants. We investigated the psychopharmacological and electrophysiological activities of 4TRP in male Swiss mice and Wistar rats. 4TRP was administered intraperitoneally (i.p.) at doses of 25 to 200 mg/kg and intracerebroventricularly (i.c.v.) at concentrations of 10, 20, and 40 ng/2 µL. For in vitro experiments, 4TRP concentrations were 0.1 mM and 1.0 mM. 4TRP (i.p.) inhibited pentylenetetrazol- (PTZ-) induced seizures, indicating anticonvulsant effects. Electroencephalographic recordings showed that 4TRP (i.c.v.) protected against PTZ-induced seizures, corroborating the behavioural results. To determine whether 4TRP exerts anticonvulsant effects via regulation of GABAergic neurotransmission, we measured convulsions induced by 3-mercapto-propionic acid (3-MP). The obtained results showed involvement of the GABAergic system in the anticonvulsant action exerted by 4TRP, but flumazenil, a selective antagonist of the benzodiazepine site of the GABAA receptor, did not reverse the anticonvulsant effect, demonstrating that 4TRP does not bind to the benzodiazepine-binding site. Furthermore, 4TRP decreased the sodium current through voltage-dependent sodium channels, and thus its anticonvulsant effect may be related to changes in neuronal excitability because of modulation of these channels.


Assuntos
Anticonvulsivantes/uso terapêutico , Convulsões/tratamento farmacológico , Terpenos/uso terapêutico , Animais , Anticonvulsivantes/química , Anticonvulsivantes/farmacologia , Comportamento Animal/efeitos dos fármacos , Sítios de Ligação , Fenômenos Eletrofisiológicos/efeitos dos fármacos , Flumazenil/farmacologia , Antagonistas de Receptores de GABA-A/farmacologia , Neurônios GABAérgicos/efeitos dos fármacos , Neurônios GABAérgicos/metabolismo , Infusões Intraventriculares , Injeções Intraperitoneais , Masculino , Camundongos , Monoterpenos/química , Monoterpenos/farmacologia , Monoterpenos/uso terapêutico , Pentilenotetrazol/toxicidade , Ratos , Ratos Wistar , Receptores de GABA-A/química , Receptores de GABA-A/metabolismo , Convulsões/induzido quimicamente , Convulsões/patologia , Terpenos/química , Terpenos/farmacologia
2.
Z Naturforsch C J Biosci ; 66(7-8): 353-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21950159

RESUMO

(R)-(+)-Pulegone is a monoterpene found in essential oils from plants of the Labiatae family. This compound is a major constituent of Agastache formosanum oil. In this study, the effect of (R)-(+)-pulegone on the central nervous system was evaluated. (R)-(+)-Pulegone caused a significant decrease in ambulation and an increase in pentobarbital-induced sleeping time in mice, indicating a central depressant effect. (+)-Pulegone also significantly increased the latency of convulsions as assessed by the pentylenetetrazole (PTZ) method. The antinociceptive properties of this monoterpene were studied in chemical and thermal models of nociception. Chemical nociception induced in the first and second phase of the subplantar formalin test was significantly inhibited by (R)-(+)-pulegone and was not blocked by naloxone. Thermal nociception was also significantly inhibited while (R)-(+)-pulegone increased the reaction latency of the mice in the hot plate test. These results suggest that (R)-(+)-pulegone is a psychoactive compound and has the profile of an analgesic drug.


Assuntos
Monoterpenos/farmacologia , Óleos Voláteis/química , Agastache/química , Animais , Comportamento Animal/efeitos dos fármacos , Monoterpenos Cicloexânicos , Masculino , Camundongos , Monoterpenos/isolamento & purificação
3.
Rev. bras. farmacogn ; 21(3): 427-431, maio-jun. 2011. ilus, graf, tab
Artigo em Inglês | LILACS | ID: lil-593286

RESUMO

It has been widely reported that the crude oil of Nigella sativa L., Ranunculaceae, seeds and its major chemical component thymoquinone present anticonvulsant activity. These facts led us to verify the pharmacological potential of five structurally related para-benzoquinones on the pentylenotetrazol-induced seizures model, and establish the structural characteristics that influence the anticonvulsant activity of thymoquinone. The unsubstituted para-benzoquinone was the compound that exhibited the highest potency, while 2-methyl-p-benzoquinone was inactive. It was found that the presence of alkyl groups attached to the ring influence the pharmacological activity of the para-benzoquinones. In addition, the number, position, and size of these groups change the anticonvulsant potency of the compounds.

4.
Nat Prod Commun ; 5(12): 1847-51, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21299105

RESUMO

The anticonvulsant activity of the racemate and enantiomers of linalool have been evaluated. Pretreatment of the mice with (S)-(+)-, (R)-(-)- and rac-linalool increased the latency of convulsions significantly in the PTZ model. Only rac-linalool had an effect at the dose of 200 mg/kg. The enantiomers and their racemic mixture were effective in inhibiting the convulsant effect of PTZ at the dose of 300 mg/kg. The linalools presented pharmacological activity close to that of diazepam. In the PIC seizure model, (R)-(-)-linalool and rac-linalool presented activity at the dose of 200 mg/kg, but the rac-linalool was more potent than (R)-(-)-linalool; (S)-(+)-linalool had no effect at this dose. On the other hand, at the dose of 300 mg/kg this enantiomer was effective, but less potent than (R)-(-)-linalool and rac-linalool. In the MES model, linalools decreased the convulsion time of the mice in the doses of 200 and 300 mg/kg. rac-Linalool presented maximum effect at 300 mg/kg. Surprisingly, it increased significantly the convulsion time at a dose of 100 mg/kg. Using the parameter of tonic hind convulsions, only (R)-(-)-linalool produced protection from tonic extension at the dose of 200 mg/kg. When the (+)- and (-)-enantiomers, and rac-linalool were administered at the dose of 300 mg/kg they were also effective in preventing tonic convulsions induced by transcorneal electroshock in the animals. The (+)- and (-)-forms were equipotent and the rac-linalool was more effective than phenytoin. We have demonstrated that the two enantiomers have similar qualitative anticonvulsant activity, but show different potencies.


Assuntos
Anticonvulsivantes/farmacologia , Monoterpenos/farmacologia , Monoterpenos Acíclicos , Animais , Masculino , Camundongos , Monoterpenos/química , Estereoisomerismo , Relação Estrutura-Atividade
5.
Z Naturforsch C J Biosci ; 64(1-2): 1-5, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19323258

RESUMO

Terpinen-4-ol is a monoterpenoid alcohol and component of the essential oils of several aromatic plants. Similarly to terpinen-4-ol, other monoterpenoid alcohols have shown anticonvulsant activity in convulsion animal models. The present study aimed to investigate the anticonvulsant activity of terpinen-4-ol. Treatment of mice with terpinen-4-ol (200 mg/kg) caused a significant decrease in the spontaneous motor activity at 30, 60 and 120 min after administration. Terpinen-4-ol (100 and 200 mg/kg) produced a significant dose-dependent increase in the duration of sleeping in mice. Pretreatment of mice with terpinen-4-ol at doses of 100, 200 and 300 mg/kg significantly increased the latency of pentylenetetrazole-induced convulsions. Terpinen-4-ol (200 and 300 mg/kg) also inhibited the induced seizures of picrotoxin. In another model, maximal electroshock seizure, terpinen-4-ol decreased the tonic hind convulsions percentage at the dose of 300 mg/kg. From the overall results we can conclude that terpinen-4-ol showed a depressant effect on the central nervous system and significant anticonvulsant activity.


Assuntos
Anticonvulsivantes/farmacologia , Convulsões/tratamento farmacológico , Terpenos/farmacologia , Animais , Anticonvulsivantes/uso terapêutico , Modelos Animais de Doenças , Eletrochoque , Hipnose , Masculino , Camundongos , Atividade Motora/efeitos dos fármacos , Fenobarbital/farmacologia , Picrotoxina , Terpenos/uso terapêutico
6.
Rev. bras. farmacogn ; 17(2): 170-175, abr.-jun. 2007. graf
Artigo em Inglês | LILACS | ID: lil-456985

RESUMO

The monoterpene alpha,beta-epoxy-carvone (EC) in doses of 200, 300 or 400 mg/kg injected by i.p. route in mice caused a significant decrease in the motor activity of animals when compared with the control group, up to 120 minutes after the administration. The doses of 300 or 400 mg/kg had induced a significant increase of in the sleeping time of animals not having modified, however, the latency. The EC in the dose of 400 mg/kg reduced the remaining time of the animals on the rotating rod (Rotarod test). These results suggest a possible central effect.


O monoterpeno alfa,beta-epóxi-carvona (EC) nas doses de 200, 300 e 400 mg/kg administrado por via i.p. em camundongos diminuiu significativamente a atividade motora dos animais, quando comparado aos controles, até 120 minutos após a administração. As doses de 300 e 400 mg/kg induziram um aumento significativo do tempo de sono dos animais não alterando, no entanto, a sua latência. O EC na dose de 400 mg/kg induziu uma redução no tempo de permanência dos animais na barra giratória (teste do rotarod). Os resultados sugerem um possível efeito central.


Assuntos
Animais , Camundongos , Monoterpenos/farmacologia , Óleos Voláteis , Farmacognosia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...